Clinical Trials Directory

Trials / Unknown

UnknownNCT05867992

Multiomic Analysis of Serum in Acute Period of Traumatic Brain Injury

Proteomic and Metabolomic Detection and Analysis of Serum from Patients with Acute Severe Traumatic Brain Injury: a Prospective, Multicentered Study

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this experimental observation study is to figure out differently expressed biomarkers in serum in traumatic brain injury patients, compared with bone fracture patients. The main questions it aims to answer are: 1. Which proteins and metabolites are differently expressed in TBI patients' serum? 2. Which proteins or metabolites can serve as the new serum biomarkers for diagnosing TBI? Participants will be treated by routine treatments, and their serum samples will be collected in the emergency room.

Detailed description

This experimental observation study is designed to find out some new characteristics in acute severe traumatic brain injury. To filter the stress response in blood, patients with traumatic fracture are chosen as the control group. Blood samples of patients who pass the eligibility criteria will be collected immediately in the emergency room. Then the samples will be preprocessed in the laboratory to get serums. These collected serums will be preserved in -80℃ until completing all sample collection. After completing collection, all samples will be sent to proteomic and metabolomic detection. The bioinformatic data will be analyzed to answer these main questions: 1. Which proteins and metabolites are differently expressed in TBI patients' serum? (As a whole characteristic of acute severe TBI) 2. Which proteins or metabolites can serve as the new serum biomarkers for diagnosing TBI? (Deeply digging the value of characteristic of acute severe TBI)

Conditions

Interventions

TypeNameDescription
OTHERType of traumaPatients in case group have the severe traumatic brain injury, while patients in control group have the traumatic bone fracture without brain injury.

Timeline

Start date
2024-06-01
Primary completion
2025-05-31
Completion
2025-12-31
First posted
2023-05-22
Last updated
2024-09-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05867992. Inclusion in this directory is not an endorsement.